SPY301.56-1.41 -0.47%
DIA253.03-1.32 -0.52%
IXIC9,343.73-25.26 -0.27%

Biohaven Pharmaceutical Q1 EPS $(2.390) Down From $(1.410) YoY

Biohaven Pharmaceutical (NYSE:BHVN) reported quarterly losses of $(2.390) per share. This is a 69.5 percent decrease over losses of $(1.410) per share from the same period last year.

Benzinga · 05/07/2020 21:06

Biohaven Pharmaceutical (NYSE:BHVN) reported quarterly losses of $(2.390) per share. This is a 69.5 percent decrease over losses of $(1.410) per share from the same period last year.